Without TGA’s approval, on March 25, 2022, ATAGI recommended a fourth dose (second booster), in some cases a 5th dose, of COVID-19 vaccine be given for certain groups and no shorter than 3 months apart.
“Comirnaty (Pfizer) or Spikevax (Moderna) are the preferred vaccines for COVID-19 booster doses including the additional winter booster dose. Vaxzevria (AstraZeneca) can be used when an mRNA vaccine is contraindicated or a person declines vaccination with an mRNA vaccine. Nuvaxovid (Novavax) can be used if no other COVID-19 vaccine is considered suitable for that person.”
It would appear that TGA have provided provisional registration for a “booster” dose, and maybe that is expected to cover any number of boosters!
The “winter booster” COVID-19 program is being rolled out with the 2022 influenza vaccination program and ATAGI says both vaccines can be administered at the same time!
ATAGI’s reasoning for the state that “[d]uring the COVID-19 pandemic, there has been reduced circulation of influenza virus and lower levels of influenza vaccine coverage compared with previous years.” But due to “borders reopening, a resurgence of influenza is expected in 2022.” Masks and other mitigation efforts are doing nothing, or could it be they’ve returned to testing for ILI again?
Compare Victoria’s Influenza Like Illness (ILI) data for yourself – see Figures 1, 2 and 3 for 2019, 2020, 2021, 2022 for yourself.
Dose upon dose upon dose and mix and match brands and “antigens”….what could go wrong?